{"DataElement":{"publicId":"4917491","version":"1","preferredName":"Non-protocol Therapy Administered Name","preferredDefinition":"The name of nonprotocol therapeutic agents administered to produce an effect that is intended to alter the course of a pathologic process.","longName":"NPROT_TX_ADM_NM","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"2188814","version":"1","preferredName":"Non-protocol Therapy Administered","preferredDefinition":"information related to the action or administration of nonprotocol therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"NPROT_MALIG_TX_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206588","version":"1","preferredName":"Non-Protocol Therapy","preferredDefinition":"Treatment not specified in a protocol.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C25590:C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Protocol","conceptCode":"C25590","definition":"Treatment not specified in a protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FB27-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E564D9BA-7EA5-2B5E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4917514","version":"1","preferredName":"Therapeutic Procedure Name","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The words or language units by which a thing is known.","longName":"Non_COG_Tx","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F13C-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"HIT-SKK","valueDescription":"HIT-SKK","ValueMeaning":{"publicId":"4917515","version":"1","preferredName":"HIT-SKK","longName":"4917515","preferredDefinition":"HIT-SKK","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F146-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F15F-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"SJMB03","valueDescription":"SJMB03","ValueMeaning":{"publicId":"4917516","version":"1","preferredName":"SJMB03","longName":"4917516","preferredDefinition":"SJMB03","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F169-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F182-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"PNET 5","valueDescription":"PNET 5","ValueMeaning":{"publicId":"4917517","version":"1","preferredName":"PNET 5","longName":"4917517","preferredDefinition":"PNET 5","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F18C-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F1A5-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"PNET 4","valueDescription":"PNET 4","ValueMeaning":{"publicId":"4917518","version":"1","preferredName":"PNET 4","longName":"4917518","preferredDefinition":"PNET 4","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F1AF-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F1C8-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"Head Start III","valueDescription":"Head Start III","ValueMeaning":{"publicId":"4917519","version":"1","preferredName":"Head Start III","longName":"4917519","preferredDefinition":"Head Start III","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F1D2-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F1EB-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"Head Start II","valueDescription":"Head Start II","ValueMeaning":{"publicId":"4917520","version":"1","preferredName":"Head Start II","longName":"4917520","preferredDefinition":"Head Start II","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F1F5-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F20E-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"Head Start I","valueDescription":"Head Start I","ValueMeaning":{"publicId":"4917521","version":"1","preferredName":"Head Start I","longName":"4917521","preferredDefinition":"Head Start I","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F218-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F231-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"VIP","valueDescription":"VIP","ValueMeaning":{"publicId":"4917522","version":"1","preferredName":"VIP","longName":"4917522","preferredDefinition":"VIP","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F246-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F25F-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"TIC","valueDescription":"TIC","ValueMeaning":{"publicId":"4917523","version":"1","preferredName":"TIC","longName":"4917523","preferredDefinition":"TIC","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F269-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F282-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"CCLG GC 2","valueDescription":"CCLG GC 2","ValueMeaning":{"publicId":"4917524","version":"1","preferredName":"CCLG GC 2","longName":"4917524","preferredDefinition":"CCLG GC 2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F28C-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F2A5-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"CCLG GC 1","valueDescription":"CCLG GC 1","ValueMeaning":{"publicId":"4917525","version":"1","preferredName":"CCLG GC 1","longName":"4917525","preferredDefinition":"CCLG GC 1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F2AF-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F2C8-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"INT-0097 (High Dose Cisplatin)","valueDescription":"INT-0097 (High Dose Cisplatin)","ValueMeaning":{"publicId":"4917526","version":"1","preferredName":"INT-0097 (High Dose Cisplatin)","longName":"4917526","preferredDefinition":"INT-0097 (High Dose Cisplatin)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F2D2-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F2EB-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"INT-0097 (Standard Dose Cisplatin)","valueDescription":"INT-0097 (Standard Dose Cisplatin)","ValueMeaning":{"publicId":"4917527","version":"1","preferredName":"INT-0097 (Standard Dose Cisplatin)","longName":"4917527","preferredDefinition":"INT-0097 (Standard Dose Cisplatin)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F2F5-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7DE510-F30E-671A-E050-BB89AD4365B3","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"BEACOPP based regimen","valueDescription":"BEACOPP based regimen","ValueMeaning":{"publicId":"4921111","version":"1","preferredName":"BEACOPP based regimen","longName":"4921111","preferredDefinition":"BEACOPP based regimen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1BA6A17D-510A-4427-E050-BB89AD434E45","latestVersionIndicator":"Yes","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1BA6A17D-5123-4427-E050-BB89AD434E45","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"ONEDATA","dateModified":"2015-07-24","deletedIndicator":"No"},{"value":"OPPA/OEPA & COPP","valueDescription":"OPPA/OEPA & COPP","ValueMeaning":{"publicId":"4921112","version":"1","preferredName":"OPPA/OEPA & COPP","longName":"4921112","preferredDefinition":"OPPA/OEPA & COPP","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1BA6A17D-512D-4427-E050-BB89AD434E45","latestVersionIndicator":"Yes","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1BA6A17D-5146-4427-E050-BB89AD434E45","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"ONEDATA","dateModified":"2015-07-24","deletedIndicator":"No"},{"value":"OPPA/OEPA","valueDescription":"OPPA/OEPA","ValueMeaning":{"publicId":"4921113","version":"1","preferredName":"OPPA/OEPA","longName":"4921113","preferredDefinition":"OPPA/OEPA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1BA6A17D-5150-4427-E050-BB89AD434E45","latestVersionIndicator":"Yes","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1BA6A17D-5169-4427-E050-BB89AD434E45","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"ONEDATA","dateModified":"2015-07-24","deletedIndicator":"No"},{"value":"ABVD based regimen","valueDescription":"ABVD based regimen","ValueMeaning":{"publicId":"4921114","version":"1","preferredName":"ABVD based regimen","longName":"4921114","preferredDefinition":"ABVD based regimen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1BA6A17D-5173-4427-E050-BB89AD434E45","latestVersionIndicator":"Yes","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1BA6A17D-518C-4427-E050-BB89AD434E45","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"ONEDATA","dateModified":"2015-07-24","deletedIndicator":"No"},{"value":"Cyclophosphamide/Topotecan","valueDescription":"Cyclophosphamide/Topotecan","ValueMeaning":{"publicId":"4921157","version":"1","preferredName":"Cyclophosphamide/Topotecan","longName":"4921157","preferredDefinition":"A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death.: A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Topotecan inhibits topoisomerase I activity by stabilizing the topoisomerase I-DNA covalent complexes during S phase of cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cyclophosphamide","conceptCode":"C405","definition":"A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Topotecan","conceptCode":"C1413","definition":"A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Topotecan inhibits topoisomerase I activity by stabilizing the topoisomerase I-DNA covalent complexes during S phase of cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1BA6A17D-51BC-4427-E050-BB89AD434E45","latestVersionIndicator":"Yes","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1BA6A17D-51D7-4427-E050-BB89AD434E45","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"ONEDATA","dateModified":"2015-07-24","deletedIndicator":"No"},{"value":"Topotecan","valueDescription":"Topotecan","ValueMeaning":{"publicId":"3380233","version":"1","preferredName":"Topotecan","longName":"3380233","preferredDefinition":"A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Topotecan inhibits topoisomerase I activity by stabilizing the topoisomerase I-DNA covalent complexes during S phase of cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Topotecan","conceptCode":"C1413","definition":"A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Topotecan inhibits topoisomerase I activity by stabilizing the topoisomerase I-DNA covalent complexes during S phase of cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B97B8401-1648-113F-E040-BB89AD431AAC","latestVersionIndicator":"Yes","beginDate":"2012-02-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1BA6A17D-51E1-4427-E050-BB89AD434E45","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"ONEDATA","dateModified":"2015-07-24","deletedIndicator":"No"},{"value":"Vincristine/Irinotecan","valueDescription":"Vincristine/Irinotecan","ValueMeaning":{"publicId":"4921158","version":"1","preferredName":"Vincristine/Irinotecan","longName":"4921158","preferredDefinition":"A natural alkaloid isolated from the plant Vinca rosea Linn. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04): A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata.  Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme.  One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death.  Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vincristine","conceptCode":"C933","definition":"A natural alkaloid isolated from the plant Vinca rosea Linn. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Irinotecan","conceptCode":"C62040","definition":"A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata.  Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme.  One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death.  Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1BA6A17D-51EE-4427-E050-BB89AD434E45","latestVersionIndicator":"Yes","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1BA6A17D-5209-4427-E050-BB89AD434E45","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"ONEDATA","dateModified":"2015-07-24","deletedIndicator":"No"},{"value":"ALCL99","valueDescription":"ALCL99","ValueMeaning":{"publicId":"4921091","version":"1","preferredName":"ALCL99","longName":"4921091","preferredDefinition":"ALCL99","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1BA5F8C3-CD49-828F-E050-BB89AD4361C0","latestVersionIndicator":"Yes","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1BA5F8C3-CD62-828F-E050-BB89AD4361C0","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"ONEDATA","dateModified":"2015-07-24","deletedIndicator":"No"},{"value":"NHL/BFM-95 (Enhanced)","valueDescription":"NHL/BFM-95 (Enhanced)","ValueMeaning":{"publicId":"4921092","version":"1","preferredName":"NHL/BFM-95 (Enhanced)","longName":"4921092","preferredDefinition":"NHL/BFM-95 (Enhanced)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1BA5F8C3-CD6C-828F-E050-BB89AD4361C0","latestVersionIndicator":"Yes","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1BA5F8C3-CD85-828F-E050-BB89AD4361C0","beginDate":"2015-07-24","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-24","modifiedBy":"ONEDATA","dateModified":"2015-07-24","deletedIndicator":"No"},{"value":"INT-0133 (Arm A)","valueDescription":"INT-0133 (Arm A)","ValueMeaning":{"publicId":"4951387","version":"1","preferredName":"INT-0133 (Arm A)","longName":"4951387","preferredDefinition":"INT-0133 (Arm A)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D252A63-B068-0C3C-E050-BB89AD43618C","latestVersionIndicator":"Yes","beginDate":"2015-08-12","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1D252A63-B081-0C3C-E050-BB89AD43618C","beginDate":"2015-07-24","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-12","modifiedBy":"ONEDATA","dateModified":"2015-08-12","deletedIndicator":"No"},{"value":"INT-0133 (Arm B)","valueDescription":"INT-0133 (Arm B)","ValueMeaning":{"publicId":"4951388","version":"1","preferredName":"INT-0133 (Arm B)","longName":"4951388","preferredDefinition":"INT-0133 (Arm B)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D252A63-B08B-0C3C-E050-BB89AD43618C","latestVersionIndicator":"Yes","beginDate":"2015-08-12","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1D252A63-B0A4-0C3C-E050-BB89AD43618C","beginDate":"2015-07-24","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-12","modifiedBy":"ONEDATA","dateModified":"2015-08-12","deletedIndicator":"No"},{"value":"VIT-C5V-D","valueDescription":"VIT-C5V-D","ValueMeaning":{"publicId":"4939111","version":"1","preferredName":"VIT-C5V-D","longName":"4939111","preferredDefinition":"VIT-C5V-D","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CAC3C3E-7549-E440-E050-BB89AD437E4D","latestVersionIndicator":"Yes","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1CAC3C3E-7562-E440-E050-BB89AD437E4D","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"ONEDATA","dateModified":"2015-08-06","deletedIndicator":"No"},{"value":"VI-C5V-D","valueDescription":"VI-C5V-D","ValueMeaning":{"publicId":"4939112","version":"1","preferredName":"VI-C5V-D","longName":"4939112","preferredDefinition":"VI-C5V-D","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CAC3C3E-756C-E440-E050-BB89AD437E4D","latestVersionIndicator":"Yes","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1CAC3C3E-7585-E440-E050-BB89AD437E4D","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"ONEDATA","dateModified":"2015-08-06","deletedIndicator":"No"},{"value":"SIOPEL VI","valueDescription":"SIOPEL VI","ValueMeaning":{"publicId":"4939113","version":"1","preferredName":"SIOPEL VI","longName":"4939113","preferredDefinition":"SIOPEL VI","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CAC3C3E-758F-E440-E050-BB89AD437E4D","latestVersionIndicator":"Yes","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1CAC3C3E-75A8-E440-E050-BB89AD437E4D","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"ONEDATA","dateModified":"2015-08-06","deletedIndicator":"No"},{"value":"SIOPEL IV","valueDescription":"SIOPEL IV","ValueMeaning":{"publicId":"4939114","version":"1","preferredName":"SIOPEL IV","longName":"4939114","preferredDefinition":"SIOPEL IV","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CAC3C3E-75B2-E440-E050-BB89AD437E4D","latestVersionIndicator":"Yes","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1CAC3C3E-75CB-E440-E050-BB89AD437E4D","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"ONEDATA","dateModified":"2015-08-06","deletedIndicator":"No"},{"value":"SIOPEL III HR","valueDescription":"SIOPEL III HR","ValueMeaning":{"publicId":"4939115","version":"1","preferredName":"SIOPEL III HR","longName":"4939115","preferredDefinition":"SIOPEL III HR","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CAC3C3E-75D5-E440-E050-BB89AD437E4D","latestVersionIndicator":"Yes","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1CAC3C3E-75EE-E440-E050-BB89AD437E4D","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"ONEDATA","dateModified":"2015-08-06","deletedIndicator":"No"},{"value":"Super PLADO","valueDescription":"Super PLADO","ValueMeaning":{"publicId":"4939116","version":"1","preferredName":"Super PLADO","longName":"4939116","preferredDefinition":"Super PLADO","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CAC3C3E-75F8-E440-E050-BB89AD437E4D","latestVersionIndicator":"Yes","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1CAC3C3E-7611-E440-E050-BB89AD437E4D","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"ONEDATA","dateModified":"2015-08-06","deletedIndicator":"No"},{"value":"PLADO","valueDescription":"PLADO","ValueMeaning":{"publicId":"4939117","version":"1","preferredName":"PLADO","longName":"4939117","preferredDefinition":"PLADO","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CAC3C3E-761B-E440-E050-BB89AD437E4D","latestVersionIndicator":"Yes","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1CAC3C3E-7634-E440-E050-BB89AD437E4D","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"ONEDATA","dateModified":"2015-08-06","deletedIndicator":"No"},{"value":"Cisplatin monotherapy","valueDescription":"Cisplatin monotherapy","ValueMeaning":{"publicId":"4939118","version":"1","preferredName":"Cisplatin monotherapy","longName":"4939118","preferredDefinition":"Cisplatin monotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CAC3C3E-763E-E440-E050-BB89AD437E4D","latestVersionIndicator":"Yes","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1CAC3C3E-7657-E440-E050-BB89AD437E4D","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"ONEDATA","dateModified":"2015-08-06","deletedIndicator":"No"},{"value":"C5V-D","valueDescription":"C5V-D","ValueMeaning":{"publicId":"4939119","version":"1","preferredName":"C5V-D","longName":"4939119","preferredDefinition":"C5V-D","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CAC3C3E-7661-E440-E050-BB89AD437E4D","latestVersionIndicator":"Yes","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1CAC3C3E-767A-E440-E050-BB89AD437E4D","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"ONEDATA","dateModified":"2015-08-06","deletedIndicator":"No"},{"value":"C5V","valueDescription":"C5V","ValueMeaning":{"publicId":"4939120","version":"1","preferredName":"C5V","longName":"4939120","preferredDefinition":"C5V","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CAC3C3E-7684-E440-E050-BB89AD437E4D","latestVersionIndicator":"Yes","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1CAC3C3E-769D-E440-E050-BB89AD437E4D","beginDate":"2015-08-06","endDate":null,"createdBy":"TSESU","dateCreated":"2015-08-06","modifiedBy":"ONEDATA","dateModified":"2015-08-06","deletedIndicator":"No"},{"value":"ICE","valueDescription":"Ifosfamide/Carboplatin/Etoposide","ValueMeaning":{"publicId":"4951431","version":"1","preferredName":"Ifosfamide/Carboplatin/Etoposide","longName":"4951431","preferredDefinition":"A synthetic analogue of the nitrogen mustard cyclophosphamide with antineoplastic activity. Ifosfamide alkylates and forms DNA crosslinks, thereby preventing DNA strand separation and DNA replication.  This agent is a prodrug that must be activated through hydroxylation by hepatic microsomal enzymes. (NCI04): A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04): A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ifosfamide","conceptCode":"C564","definition":"A synthetic analogue of the nitrogen mustard cyclophosphamide with antineoplastic activity. Ifosfamide alkylates and forms DNA crosslinks, thereby preventing DNA strand separation and DNA replication.  This agent is a prodrug that must be activated through hydroxylation by hepatic microsomal enzymes. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Carboplatin","conceptCode":"C1282","definition":"A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Etoposide","conceptCode":"C491","definition":"A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D2582AE-7FFA-0E42-E050-BB89AD435096","latestVersionIndicator":"Yes","beginDate":"2015-08-12","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1D2582AE-8013-0E42-E050-BB89AD435096","beginDate":"2015-08-12","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-12","modifiedBy":"ONEDATA","dateModified":"2015-08-12","deletedIndicator":"No"},{"value":"St. Jude Total","valueDescription":"St. Jude Total","ValueMeaning":{"publicId":"6334917","version":"1","preferredName":"St. Jude Total","longName":"6334917","preferredDefinition":"St. Jude Total","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E7B1B6E-7DBD-5D95-E053-F662850AC639","latestVersionIndicator":"Yes","beginDate":"2018-06-12","endDate":null,"createdBy":"HAMMA","dateCreated":"2018-06-12","modifiedBy":"ONEDATA","dateModified":"2018-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6E7B1B6E-7DD6-5D95-E053-F662850AC639","beginDate":"2018-06-12","endDate":null,"createdBy":"HAMMA","dateCreated":"2018-06-12","modifiedBy":"ONEDATA","dateModified":"2018-06-12","deletedIndicator":"No"},{"value":"AIEOP-BFM 2000/2009","valueDescription":"AIEOP-BFM 2000/2009","ValueMeaning":{"publicId":"6334918","version":"1","preferredName":"AIEOP-BFM 2000/2009","longName":"6334918","preferredDefinition":"AIEOP-BFM 2000/2009","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E7B1B6E-7DE0-5D95-E053-F662850AC639","latestVersionIndicator":"Yes","beginDate":"2018-06-12","endDate":null,"createdBy":"HAMMA","dateCreated":"2018-06-12","modifiedBy":"ONEDATA","dateModified":"2018-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6E7B1B6E-7DF9-5D95-E053-F662850AC639","beginDate":"2018-06-12","endDate":null,"createdBy":"HAMMA","dateCreated":"2018-06-12","modifiedBy":"ONEDATA","dateModified":"2018-06-12","deletedIndicator":"No"},{"value":"DFCI","valueDescription":"DFCI","ValueMeaning":{"publicId":"6334919","version":"1","preferredName":"DFCI","longName":"6334919","preferredDefinition":"DFCI","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E7B1B6E-7E03-5D95-E053-F662850AC639","latestVersionIndicator":"Yes","beginDate":"2018-06-12","endDate":null,"createdBy":"HAMMA","dateCreated":"2018-06-12","modifiedBy":"ONEDATA","dateModified":"2018-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6E7B1B6E-7E1C-5D95-E053-F662850AC639","beginDate":"2018-06-12","endDate":null,"createdBy":"HAMMA","dateCreated":"2018-06-12","modifiedBy":"ONEDATA","dateModified":"2018-06-12","deletedIndicator":"No"},{"value":"Interfant 06","valueDescription":"Interfant 06","ValueMeaning":{"publicId":"6334920","version":"1","preferredName":"Interfant 06","longName":"6334920","preferredDefinition":"A clinical study protocol initiated in 2006 designed to improve the treatment for infant acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interfant-06 Protocol","conceptCode":"C156939","definition":"A clinical study protocol initiated in 2006 designed to improve the treatment for infant acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E7B1B6E-7E26-5D95-E053-F662850AC639","latestVersionIndicator":"Yes","beginDate":"2018-06-12","endDate":null,"createdBy":"HAMMA","dateCreated":"2018-06-12","modifiedBy":"COOPERM","dateModified":"2019-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6E7B1B6E-7E3F-5D95-E053-F662850AC639","beginDate":"2018-06-12","endDate":null,"createdBy":"HAMMA","dateCreated":"2018-06-12","modifiedBy":"ONEDATA","dateModified":"2018-06-12","deletedIndicator":"No"},{"value":"Head Start IV","valueDescription":null,"ValueMeaning":{"publicId":"14478167","version":"1","preferredName":"Head Start IV","longName":"14478167v1.00","preferredDefinition":"Head Start IV","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05A79882-0187-1299-E063-731AD00AE82A","latestVersionIndicator":"Yes","beginDate":"2023-09-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-09-18","modifiedBy":"MMADDINENI","dateModified":"2023-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05A79882-018B-1299-E063-731AD00AE82A","beginDate":"2023-09-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-09-18","modifiedBy":"MMADDINENI","dateModified":"2023-09-18","deletedIndicator":"No"},{"value":"SIOPe-CONNECT LRMB","valueDescription":null,"ValueMeaning":{"publicId":"14478168","version":"1","preferredName":"SIOPe-CONNECT LRMB","longName":"14478168v1.00","preferredDefinition":"SIOPe-CONNECT LRMB","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05A79882-0188-1299-E063-731AD00AE82A","latestVersionIndicator":"Yes","beginDate":"2023-09-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-09-18","modifiedBy":"MMADDINENI","dateModified":"2023-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05A79882-018C-1299-E063-731AD00AE82A","beginDate":"2023-09-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-09-18","modifiedBy":"MMADDINENI","dateModified":"2023-09-18","deletedIndicator":"No"},{"value":"SJMB12","valueDescription":null,"ValueMeaning":{"publicId":"14478169","version":"1","preferredName":"SJMB12","longName":"14478169v1.00","preferredDefinition":"SJMB12","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05A79882-0189-1299-E063-731AD00AE82A","latestVersionIndicator":"Yes","beginDate":"2023-09-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-09-18","modifiedBy":"MMADDINENI","dateModified":"2023-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05A79882-018D-1299-E063-731AD00AE82A","beginDate":"2023-09-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-09-18","modifiedBy":"MMADDINENI","dateModified":"2023-09-18","deletedIndicator":"No"},{"value":"SJYCO7","valueDescription":null,"ValueMeaning":{"publicId":"14478170","version":"1","preferredName":"SJYCO7","longName":"14478170v1.00","preferredDefinition":"SJYCO7","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05A79882-018A-1299-E063-731AD00AE82A","latestVersionIndicator":"Yes","beginDate":"2023-09-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-09-18","modifiedBy":"MMADDINENI","dateModified":"2023-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05A79882-018E-1299-E063-731AD00AE82A","beginDate":"2023-09-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-09-18","modifiedBy":"MMADDINENI","dateModified":"2023-09-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3629877","version":"1","preferredName":"Therapeutic Procedure Name","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.:The words or language units by which a thing is known.","longName":"C49236:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF54A49-4A73-0AB2-E040-BB89AD431994","latestVersionIndicator":"Yes","beginDate":"2012-11-20","endDate":null,"createdBy":"KNUTSOND","dateCreated":"2012-11-20","modifiedBy":"ONEDATA","dateModified":"2012-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7DE510-F12A-671A-E050-BB89AD4365B3","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"MMADDINENI","dateModified":"2023-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Select regimen administered:","type":"Preferred Question Text","description":"Select regimen administered:","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Select study or regimen administered:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7D361F-414D-8E0C-E050-BB89AD43272E","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"TSESU","dateCreated":"2015-07-22","modifiedBy":"HAMMA","dateModified":"2018-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}